Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 13/20 | 0.58 |
| ▸ | NPY1R | P25929 | 9/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.58 |
| ▸ | NPY2R | P49146 | 5/20 | 0.58 |
| ▸ | BACE1 | P56817 | 3/20 | 0.54 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.53 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31314356 | 0.92 | NPY4R (0.59) | NPY4RNPY1RNPY5RNPY2RBACE1 | |
| SCHEMBL30310193 | 0.92 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RBACE1 | |
| SCHEMBL29625333 | 0.91 | NPY4R (0.57) | NPY4RNPY1RNPY5RNPY2RBACE1 | |
| SCHEMBL30175896 | 0.90 | BACE1 (0.68) | NPY4RNPY1RNPY5RNPY2RBACE1 | |
| SCHEMBL5598820 | 0.90 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL5598812 | 0.90 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31184322 | 0.90 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL31184376 | 0.90 | NPY4R (0.55) | NPY4RNPY1RNPY5RNPY2RKISS1R | |
| SCHEMBL8722013 | 0.89 | BACE1 (0.58) | NPY4RNPY1RNPY5RNPY2RBACE1 | |
| SCHEMBL8722030 | 0.89 | BACE1 (0.58) | NPY4RNPY1RNPY5RNPY2RBACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4196495-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP Pharma GmbH (CH) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022034062-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP PHARMA AG (CH) | 2022-02-17 | — | — | WO | disclosed |